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Abstract: Traditionally, pollution risk assessment is based on the measurement of a 
pollutant’s total concentration in a sample. The toxicity of a given pollutant in the 
environment, however, is tightly linked to its bioavailability, which may differ significantly 
from the total amount. Physico-chemical and biological parameters strongly influence 
pollutant fate in terms of leaching, sequestration and biodegradation. Bacterial sensor-
reporters, which consist of living micro-organisms genetically engineered to produce 
specific output in response to target chemicals, offer an interesting alternative to monitoring 
approaches. Bacterial sensor-reporters detect bioavailable and/or bioaccessible compound 
fractions in samples. Currently, a variety of environmental pollutants can be targeted by 
specific biosensor-reporters. Although most of such strains are still confined to the lab, 
several recent reports have demonstrated utility of bacterial sensing-reporting in the field, 
with method detection limits in the nanomolar range. This review illustrates the general 
design principles for bacterial sensor-reporters, presents an overview of the existing 
biosensor-reporter strains with emphasis on organic compound detection. A specific focus 
throughout is on the concepts of bioavailability and bioaccessibility, and how bacteria-based 
sensing-reporting systems can help to improve our basic understanding of the different 
processes at work. 
Keywords: whole-cell living bioreporters, luciferase, gfp, beta-galactosidase, 
bioremediation, synthetic biology. 
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Introduction 
Sensing techniques form an integrated part of our modern life. We like to be accurately and 
constantly informed about the quality, security and composition of products that we consume or 
encounter in our daily life. Medical tests need to provide instantaneous answers on health parameters, 
blood values or presence of potential pathogenic organisms. Industrial processes rely on constant 
physical and chemical sensing of process parameters, system inflow or outflow. Sensors come in 
thousand and more forms and shapes, principles and output. Future demand calls for further 
miniaturization, continuous sensing, rapidity, increased sensitivity or flexibility.  
One of the emerging domains in sensing technology is the use of living (microbial) cells or 
organisms. Whereas this principle is arguable very old (for example, mine canaries were used in 
Roman times to sense carbon monoxide), it is only since the last twenty years that living cell-based 
sensing assays have gained impetus and developed into a scientific and technological area by itself. 
The question we would like to discuss here is why one would use living cells and organisms for 
sensing? What are the specific purposes for basing sensing methods on living cells and what are the 
advantages that cellular-based sensing can have over other sensing techniques? In this overview we 
will concentrate specifically on bacteria- (microbe-) based sensor (MBS) methods. We will shortly 
rehearse the major design principles in MBS and give some examples of potentially useful applications 
that have been achieved up to now. Furthermore, we will focus our attention on the concepts 
bioavailability and bioaccessibility, which are useful to explain the central conceptual differences 
between sensing based on living cells and other sensing methods.  
Microbe-based sensors (MBS) 
Initiated almost twenty years ago [1], the engineering of microbial cells with the purpose of 
chemical detection has enormously expanded since [2-4]. The major driving force for this development 
has been the advance in genetic engineering techniques; the relative ease to redesign (certain) 
hardware components in microbial cells and to assemble synthetic genetic circuitry for sensing and 
producing robust output signals. Although in principle any constituent, product or reaction of living 
cells can form the basis for a ‘sensing device’, most research has concentrated on non-cognate so-
called reporter proteins that are to be produced by the cell after specific contact or interaction with a 
target analyte or condition [5,6]. The use of non-cognate proteins as reporters ensures a low 
background in the absence of the trigger, and, ideally, a highly specific output signal [3,7,8]. In 
addition, the conditional synthesis of the reporter protein is an important prerequisite for a high signal-
to-noise ratio.  
The choice of a suitable reporter protein is dependent on the targeted application form. For 
example, MBS used for in-situ single-cell measurements often apply autofluorescent proteins as 
reporters [9,10]. A large variety of autofluorescent proteins with different spectral properties, 
maturation kinetics, photobleaching or temperature stability is now available, mostly but not 
exclusively based on mutants of green fluorescent protein (GFP) or DsRed [11,12]. Recently, a new 
type of fluorescent protein based on the YtvA protein of Bacillus subtilis and Pseudomonas putida was 
developed that can produce fluorescence even in the absence of oxygen, a characteristic which GFP 
does not have [13]. Bulk measurements of MBS have been carried out with several different types of 
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reporter proteins [3], of which bacterial and eukaryotic luciferases have been particularly popular 
[7,14]. Mostly because of their relatively high quantum yields, luciferases have been the optimal 
choice for highly sensitive applications. Different spectral variants have been developed by 
mutagenesis strategies [15,16]. On the other hand, eukaryotic luciferases require substrate addition and 
cell membrane permeabilization in bacteria, which somewhat limits their practicality for MBS assay 
configurations. Bacterial luciferases have been the most applied reporters in MBS. Two different 
configurations have been used, one (LuxCDABE), in which the cells synthesize the substrate for the 
luciferase, and another (LuxAB), in which external substrate addition is needed [7,14]. Although 
external substrate addition is somewhat more cumbersome, it avoids false-positive stimulation of 
luciferase activity by membrane regeneration [17] and is less energy demanding for the cell. Other 
reporter proteins can be used for colorimetric or electrochemical detection [3]. Of these, beta-
galactosidase is currently probably the most versatile, because a large variety of substrates is available 
for different detection purposes.  
 
Figure 1. Concept of a bacterial sensor-reporter cell. 
(a) DNA parts necessary for constructing an inducible sensor-reporter circuit. Parts can be 
combined and assembled by genetic engineering techniques. Regulatory and reporter genes 
are necessary for the sensing function and system output, respectively. Promoter, operator(s), 
terminators, ribosome binding sites, etc. are DNA sequences needed for control of the gene 
expression. (b) Set-up in which the sensor function is provided by a single regulatory protein. 
In this example, the regulator protein binds the target compound and induces the transcription 
of the reporter gene, leading to the production of reporter proteins (signal amplification). (c) 
Set-up for separated sensor and regulator functions. In this configuration, the target compound 
is sensed by a periplasmic receiver protein that transmits the detection event via a signalling 
(e.g. phosphorylation) cascade to the regulatory protein (zigzag arrow). The activated 
regulator then induces reporter gene expression as before. 
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In most of the current designs, the de novo synthesis of reporter protein is under control of a 
transcription factor, which directs the repression or induction of reporter gene expression from a 
dedicated site on the DNA (e.g., promoter). The sensory function can be provided by the transcription 
factor itself via, for instance, an internal effector binding domain that transmits target perception to 
forming productive interactions with RNA polymerase [7], or via a sensory protein, which 
subsequently transmits the perception event via a signalling cascade (e.g., phosphorylation) to the 
ultimate transcription regulator [18] (Fig. 1). Sensing events are thus translated and amplified in the 
form of reporter protein synthesis, the activity of which is generally measured in the assay (resulting in 
further signal amplification). The specificity of target detection is determined by the recognition 
specificity of the primary sensor protein or transcription factor, and by any other condition influencing 
the signaling cascade or acting on the same promoter [19]. The construction of the genetic circuitry for 
the sensor-reporter conditional switch is accomplished by established recombinant DNA technology 
or, more and more, by direct DNA synthesis. Dedicated resources have become available that list 
available biological parts and their specifications needed for the circuitry, much like catalogues of 
electronic parts (http://partsregistry.org/Main_Page, Fig. 1). Due to the ease of manipulation, bacteria 
such as Escherichia coli are very often used as host cells for the sensor-reporter constructs, but 
likewise have yeast [20] or human cell lines [21] been employed. Many different instruments can be 
used for the measurement of the reporter signal, and both populations of sensor-reporter cells (i.e., 
bulk measurements) or individual cells can serve as basis for reporter analysis (Fig. 2). 
Bioavailability 
Are there specific advantages for exploiting living cells for sensory purposes rather than e.g., 
physico-chemical detectors, or even purified proteins and antibodies? Obviously, in order for the 
sensor-reporter construct to operate, the MBS need to be maintained alive and in some sort of active 
state and optimal environment to produce the required response. This requirement in practise puts 
serious constraints on the shelf-life of MBS. On the other hand, MBS are self-propagating entities and 
therefore relatively easy and cheap to produce. The fact that different MBS can be engineered, which 
solely differ in target recognition but otherwise have the same reporter output signal, may pave the 
way for sensing arrays while maintaining relatively simple detectors and devices [4] (box 1). The main 
important advantage for using MBS, however, that (for the time being) only cells themselves can 
provide is the integration of biological processes relevant to the target one would like to address. 
Cellular toxicity, for instance, is conceptually most easily determined by the cell in question itself, if 
we succeed in interrogating the appropriate biochemical elements in the cell. Bacterial pollutant 
degradation activity (another domain where MBS are used) is most accurately measured by the 
bacterial cells themselves, which we can translate into a useful reporter signal when directing the 
dedicated genetic sensor-reporter circuit to the appropriate key elements in the cell. In the following, 
we will thus argue that the key advance made by MBS is to analyze biologically relevant processes 
while providing at the same time a certain analogue (the bioavailability or bioaccessibility fraction) to 
classical chemically derived compound concentrations (or chemical ‘activities’). This is most easily 
explained in the form of the example of pollutant remediation and environmental risk assessment. 
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Figure 2. Schematic analysis of an MBS-assay.  
(a) Typical calibration curve with reporter output as a function of analyte concentration, 
produced from incubations with a set of known analyte concentrations. Output from an 
unknown sample is interpolated on the calibration curve (dotted lines), analyzed at the same 
time and under the same conditions, to derive a value of 'equivalent target compound 
concentration'. Additional spiking assays can be performed (i.e., adding known target 
amounts to unknown samples) to correct for possible sample interferences or presence of 
toxic compounds. (b) Time-dependent signal calibration. MBS-assays are usually carried out 
in such a manner that output values are relative: dependent on incubation time and amount of 
cells in the assay. Her as an example curves t2 and t1 for longer and shorter incubations, 
respectively. For this reason, simultaneous calibration curves must accompany analysis of 
unknowns. (c) Various instruments for measuring reporter output, here shown as an example 
for three currently used reporter activities: fluorescence, bio- or chemiluminescence, and 
colorimetry.  
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Bioremediation and risk assessment 
Environmental risk assessment is an essential tool in the investigation of polluted sites and the 
subsequent decision making process on the eventuality of active site remediation. In Switzerland 
alone, some 50’000 polluted sites have been entered in inventory – among which 4’000 may represent 
a danger for environment and will have to be treated in the next 15 years [22]. Obviously, there is 
insufficient public funding available for an extensive treatment of every site, and thus priorities have to 
be set on the basis of pollution exposure and risks. Current regulations most often base on total 
pollutant concentrations at a site for predicting risks. However, most likely only a fraction of the total 
amount of hazardous substance will actually have an impact on living organisms (by definition, the 
fraction which is available or accessible to the organisms). Therefore, the use of the total amount is 
likely to overestimate the risk [23]. The discrepancy between the total and the bioavailable or 
bioaccessible fractions is particularly significant in the case of contaminants with poor aqueous 
solubility (e.g., PCBs, PAHs) or very low dissociation constants (e.g., certain heavy metal 
precipitates). Nowadays, increasing attention is thus given to bioavailability assays that better predict 
the real exposure of specific organisms to pollutants [24]. 
Although the term bioavailability is frequently used in scientific papers, it does not always have the 
same definition. For this reason, other authors preferred to speak of bioavailability processes, to reflect 
the fact that various biological, chemical or physical steps influence the final outcome [24]. In this 
review, we will use Semple’s definition of bioavailability as the fraction of a chemical in a system 
“which is freely available to cross an organisms’s (cellular) membrane from the medium the organism 
inhabits at a given point in time” [25,26]. The authors further suggested using the term bioaccessibility 
to dinstinguish the fraction that could potentially cross the cellular membrane if the organism had 
access to it. A bioaccessible fraction can become bioavailable over time or in space if physical barriers 
that restrict access to the organism are relieved. Organisms themselves can influence the bioaccessible 
fraction by changing the compound mass-transfer rate to the cells [27]. For example, a bacterium 
metabolizing a poorly water-soluble carbon compound will deplete this from solution, which can drive 
further dissolution from a solid phase. Semple et al. argued that it would be useful to differentiate 
chemically active compound (bioavailable) from chemically inactive but potentially exploitable 
(bioaccessible), and that for risk assessment the bioaccessible fraction would be the more relevant 
determinant. Bioaccessibility is inherently organism-dependent [24], but its actual (numeric) value 
may be the same among various organisms. Therefore, model organisms such as MBSs may be useful 
to assay bioaccessibility.  
Bioavailability and bioaccessibility assays with MBS 
We could thus envision different types of bioassays targeting compound bioavailability and 
bioaccessibility. A typical MBS assay consists of incubating the cells in an aqueous sample for a 
particular pre-defined reaction period, after which the reporter signal is determined (Fig. 2). Because in 
this case the sensor-reporter cells can be assumed not to have been limited by the access of the 
compound in solution (i.e., no mass transfer limitation existed), they must have detected the fraction 
which was bioavailable to them during the assay period. We will see that this is essentially the case, 
although metabolic decisions in cells can still influence the behaviour of the sensor-reporter [19,28]. 
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Bioaccessibility assays are trickier to perform, because in essence they have to somehow overcome the 
time or spatial barrier that prevents further compound transfer to the cells. Chemically, bioaccessibility 
can be tested by using so called non-exhaustive extraction techniques (NEETs). NEETs employ, for 
instance, Tenax or cyclodextrins to rapidly retrieve a compound fraction from the sample that is 
similar to the fraction metabolized by (micro-) organisms during a much longer incubation period 
[29,30]. For example, Dick et al. added [14C]-labeled phenanthrene or pyrene to soils, and showed that 
the total fraction of PAHs metabolized by bacteria in the soil during thirty days as derived from [14C]-
CO2 evolution was almost the same as the PAH-amount extracted by hydroxypropyl-beta-cyclodextrin 
[30]. In a MBS assay, this might be imitated by using sensor-reporter cells which not only detect, but 
also metabolize the target compound. These cells will create a mass transfer flux during the assay and 
may thus more faithfully detect the bioaccessible fraction (Fig. 3). For the remainder we will discuss a 
number of MBS assays specifically in the light of bioavailability – bioaccessibility detection of organic 
chemicals. 
Figure 3. 'Equilibrium' versus 'sink' sensor-reporter cells to differentiate between bioavailable 
and bioaccessible fractions. (a) Microbe-based sensors (MBS) which do not degrade the 
analyte rely on the aqueous phase concentration or chemical activity. An equilibrium will 
arise between bulk aqueous phase concentration, lipid fraction and intracellular compound 
concentration (the latter more or less equalling the aqueous phase concentration). The MBS 
can only sense the immediate or bioavailable fraction. (b) MBS that can degrade the analyte. 
By degrading the analyte, a flux is created from the pollutant compartment to the biological 
compartment. The MBS thus acts as a 'sink' and can detect part of the bioaccessible fraction. 
Thickness of the arrow points to the pollutant flux from one compartment to the other. The 
MBS cell here is depicted as a square box. 
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MBS detection of benzene, toluene, ethylbenzene and xylenes 
In a number of MBS-assays so-called BTEX compounds were addressed. BTEX stands for 
benzene, toluene, ethylbenzene and xylene; four volatile aromatic compounds that are found in crude 
oil, gasoline and natural gas. BTEX are also massively produced by industry as solvent and starting 
materials for chemical synthesis, and are considered as one of the major environmental pollutant 
classes [31-33]. The four compounds have various toxic effects, including blood disorder, impact on 
the central nervous, reproductive and respiratory systems, whereas benzene is also a known carcinogen 
[34]. Because BTEX compounds are rather water soluble (e.g., up to 1.8 g/L for benzene [35]), they 
represent a risk for drinking water pollution [34]. On the other hand, their volatility and 
hydrophobicity make it hard to predict their bioavailability and bioaccessibility.  
The first MBSs for the detection of BTEX and related compounds were created more than ten years 
ago using the regulatory protein XylR and the Pu promoter from the xylene degradation pathway on the 
TOL plasmid of the bacterium Pseudomonas putida mt-2 as a conditional switch [36,37]. One of these 
consisted of an Escherichia coli strain carrying the plasmid pGLUTR, which expresses firefly 
luciferase (luc gene) from the XylR-Pu system [38]. Other MBSs for BTEX used the TodST sensor-
regulatory proteins and the PtodX promoter from the toluene degradation pathway of Pseudomonas 
putida F1, coupled to expression of bacterial luciferase [39-41]. Also the regulatory protein TbuT and 
the PtbuA1 promoter from the toluene degradation pathway in Ralstonia pickettii PKO1 have been used 
as a basis for a BTEX-MBS, this time exploiting Pseudomonas fluorescens A506 (pTS) as a host strain 
expressing the green fluorescent protein (gfp) as reporter [42]. Both E. coli DH5alpha (pGLUTR) and 
P. fluorescens A506 (pTS) were not able to degrade BTEX compounds, whereas the MBSs employing 
the TodST-PtodX constructions was. Interestingly, the presence of other carbon substrates diminished 
the reporter output from P. putida F1-PtodX-luxAB [41]. The authors explained this behaviour by 
assuming that multiple usable carbon substrates diluted the metabolic flux through the toluene pathway 
[41]. Although this can be considered as a hindrance for successful use of the MBS for bioaccessibility 
measurements, the system does present a faithful reaction of the cells. This implies that in this case 
toluene bioaccessibility is diminished because of simultaneous presence of other compounds. Even the 
non-degrading MBS for BTEX did not in all cases respond to the available fraction in aqueous 
solution, because of metabolic interference at the Pu-promoter. This promoter is especially prone to 
secondary control, such as via the phenomenon of ‘exponential phase silencing’ [43]. The result of this 
interference is that the promoter is not induced even though sufficient toluene is present for the cell.  
As outlined above, in most assays the MBS were calibrated in aqueous solution with known BTEX 
concentrations. The reporter signal produced from unknown aqueous sample incubations is 
interpolated on the calibration curve, from which a so-called BTEX-equivalent concentration can be 
derived (box 1). In order to appropriately estimate BTEX availability and accessibility in contaminated 
soils, samples have been extracted and the extract incubated in the MBS assay. Willardson et al. 
attempted to extract soils with ethanol and add the ethanol extract in the MBS-assay. A dilution of 
almost twenty times had to be used, at which ethanol concentration still ≈ 40% inhibition of the cells 
occurred. This resulted in a BTEX detection limit of 30 mg/L [38]. Other groups used soil-water 
extracts [44,45], and showed that toluene-equivalent concentrations determined in the MBS-assay 
were similar as the total concentration of ethylbenzene plus benzene in the soil-pore aqueous phase by 
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GC-MS [45]. Dawson further compared BTEX degradation in soil over a 30-days time period and 
measured toluene-equivalent concentrations in the soil-water extract by their BTEX-biosensor. They 
showed that the MBS detected less-and-less over time as biodegradation proceeded, but no correlation 
was made to the total BTEX load in the soil determined by methanol extraction and GC [44]. From 
these studies we can thus conclude that MBS detect bioavailable fractions in soil-water extracts which 
are similar as the dissolved chemical concentration (except in the case of metabolic interference as 
discussed above). Organic extractions on the other hand, retrieve higher BTEX fractions from soil, 
and, therefore, MBS-assays on the organic solvent extracts provide an idea about the bioaccessible 
fraction. Disadvantage of use of organic phases is that they easily inhibit the cells in the assay. For this 
reason, the extracts have to be used in highly diluted form. 
Very few studies actually investigated BTEX availability and accessibility fractions in soil without 
the introduction of an extraction step. In principle, an incubation of MBS cells with the sample and 
subsequent retrieval and measurement of the MBS reporter signal at different incubation time periods 
would show the immediate response (i.e., bioavailable fraction) and the slow released fraction 
(bioaccessible). An excellent example of this principle was provided by Leveau et al. [46], who 
analyzed fructose bioaccessibility on plant leaves. Casavant and colleagues [47] developed a similar 
idea for monitoring toluene availability in planta. However, their sensor-reporter system did not show 
a dosage effect, but only produced a yes-or-no signal. From the number of individual MBS cells 
expressing GFP isolated from the exposed plant root they could infer the past exposure to toluene. 
These biosensor cells did not degrade the target compound and, therefore, only detected the 
bioavailable fraction of toluene in the system above the threshold needed to trigger the response. Also 
in this study, the authors observed that the MBS was influenced by indigenous chemicals such as 
isoprene, which led to GFP induction.  
The bioavailability problem of very poorly water soluble compounds 
The distinction between bioavailability and bioaccessibility becomes even more pronounced for 
polycyclic aromatic hydrocarbons (PAHs) than for BTEX. PAHs comprise a large group of 
compounds (>100 chemicals studied), most of which have no direct commercial use. They consist of 
two or more fused aromatic rings, have an elevated melting point and poor water solublity, and are 
typically formed during incomplete burning of organic material [48]. Combustion of coal, oil, gas and 
garbage are common sources of PAH production, but they can be found in cigarette smoke or grilled 
meat as well. PAHs in the environment mostly occur in sorbed form to organic matter or soil particles 
[48]. Apart from their acute toxicity, some PAHs are known or suspected carcinogens and they 
accumulate in animal tissue [35]. PAH biodegradation rates are strongly dependent on the chemical 
nature and number of aromatic rings, and are generally strongly limited by poor aqueous solubility 
[49]. For all these reasons, it is extremely important to have accurate measurements of PAH 
bioavailability and bioaccessibility, and in a variety of environments. 
Bacterial MBS have mostly been designed for naphthalene(s) – a two-ring PAH of low molecular 
weight and moderate solubility in water – because of the known genetic details on naphthalene 
degradation [50-52]. Naphthalene-sensing MBS have typically applied the NahR regulatory protein in 
conjunction with the Psal or Pnah promoters from the NAH7 plasmid of P. putida pPG7 [1,53]. 
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Interestingly, use of this genetic circuit automatically leads to the detection of a metabolic ‘flux’ rather 
than of equilibrium concentration, since the chemical effector for NahR is not naphthalene but its 
metabolite salicylate [51]. Naphthalene needs to be metabolized by the MBS in order to generate 
internal salicylate, which then triggers reporter protein synthesis. Once in fully ‘activated’ state, the 
flux through the naphthalene pathway is high and internal salicylate concentrations will be low. Cells 
thus act as a sink for naphthalene and drive naphthalene diffusion toward them, a prerequisite for 
bioaccessibility assays [52]. A fluorene-targeting MBS was developed on the basis of randomly 
introducing a luxAB transposon into Sphingomonas sp. strain L-132 [54]. Although these cells could 
no longer completely metabolize fluorene as a consequence of the transposon insertion, they still 
partially transformed the compound and thus continue to act as sink. The strain detected fluorene 
concentrations as low as 200 µg/L (1.2 µM) in aqueous phase with a response time of between 30 min 
and 4 h. A phenanthrene-detecting MBS was constructed using Burkholderia sartisoli strain RP037. 
This strain produced GFP after contact with phenanthrene and naphthalene under control of the 
regulatory protein PhnR and its activated promoter PphnS [55]. PAHs have also been assessed with the 
help of a sensor-reporter strain induced by a toxicity-response invoked by PAHs [56,57].  
MBS-assays for PAHs demonstrated that the cells are very sensitive to mass-transfer processes and 
are easily limited by the aqueous phase concentration. For example, the detection limit for naphthalene 
was lowered from 0.5 µM to 50 nM by using an MBS-assay in the gas-phase rather than in aqueous 
suspension [58,59]. This is due to the high volatility of naphthalene and the ~10’000 times faster 
diffusion rates in air than in liquid [58]. Kohlmeier and colleagues then could further show that 
biosensor-reporter cells exposed to saturated naphthalene concentrations in aqueous solution without 
or with further naphthalene crystals produced the same maximum GFP reporter output after 4 hrs 
incubation time. However, cells in the assay with crystalline naphthalene continued to grow, leading to 
a dilution of the amount of GFP in the cells at incubations longer than 4 h as a consequence of the 
activated state of the naphthalene metabolic pathway (as explained above) [59]. This demonstrated that 
such cells can be used to differentiate naphthalene bioavailability (4 h measurement) and 
bioaccessibility (20 h measurement). 
For PAHs with higher molecular weight, volatility is strongly reduced and the advantage for 
measuring with MBS in the gas phase is abolished. For this class of compounds the aqueous solubility 
strongly limits their bioavailability to the cells. Simple ‘calibration’ of the MBS-assay by incubating 
with different aqueous concentrations of the target compound no longer produces sufficiently different 
reporter activities in the cell. In that case, it becomes an option to calibrate the MBS on the basis of 
metabolic flux instead of equilibrium concentration (Fig. 3). We illustrated this possibility by using the 
B. sartisoli strain RP037 phenanthrene-sensing MBS [55]. B. sartisoli cells produce a stable GFP in 
response to phenanthrene metabolism. Probably because growth rates on phenanthrene are slower than 
the GFP synthesis rates, cells experiencing differences in phenanthrene flux produce more GFP over 
time. Four days-exposure times were required in order to obtain optimal signal-to-noise ratio, but this 
allowed us to calculate bioaccessible fractions for phenanthrene loadings in different materials, or from 
different surface areas [55].  
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Box 1. Multi-target biosensor analysis.  
Because a single bacterial host strain can be implemented with a wide diversity of genetic 
reporter circuits, multi-target arrays can be designed. The bacterium Escherichia coli is a long 
known laboratory ‘pet’ organism, whose growth and maintenance are easy and well 
controllable. For this reason, this bacterium has often been used as a host strain for sensor-
reporter constructions and various reporter strains of E. coli are now available for a diversity 
of target chemicals. Since only small volumes of aqueous sample are required for an MBS-
assay, a single sample can be tested against a battery of sensors with different target 
specificities. (a) Two liters of sea water were contaminated with 1% (v/v) of crude oil in a 
glass flask. Two hours after the addition of oil, water was sampled via the tap and analyzed 
for three compound classes in parallel, alkanes, BTEX and 2-hydroxybiphenyl. (b, c and d) 
Typical calibration curves with pure compounds in uncontaminated sea water. Output values 
obtained from the contaminated sample and from a spiked sample are indicated. Spiking 
consists of adding a known concentration of inducer (indicated by a star) that allows us to 
verify if the MBS is reporting satisfactorily. Data: R. Tecon and S. Beggah (unpublished).  
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MBS for toxic organic compounds 
Phenol and derivatives are widespread contaminants whose sources are both natural and industrial. 
Phenol is massively produced and used as a starting material for synthetic polymers and fibers. Phenol 
is a strong irritant and long time exposure can cause a wide variety of health damages, including 
effects on the immune system [60]. Various phenol derivatives are known for their toxic action. 
Examples include 2-hydroxybiphenyl, a common disinfectant and fungicide, and 2,4-
dichlorophenoxyacetic acid (2,4-D), a widely used herbicide that can cause nervous system damage in 
humans. One of the main metabolites of 2,4-D is 2,4-dichlorophenol (DCP), a proton shuttle and 
dissipator of membrane potential [61]. Various MBS have been developed to target phenolics, and 
have usually been based on bacteria degrading them. 
Some of the earliest MBS for phenols were based on the regulatory protein DmpR and the Po 
promoter from the plasmid pVI150 of Pseudomonas sp. strain CF600. One MBS of this type, the strain 
P. putida KT2440::DmpR (pVI360), could be activated by phenol, cresols and some dimethylphenols, 
but did not respond to dichlorophenols or BTEX [62]. Similar MBS were constructed using the CapR-
system from P. putida KCTC1453 [63] or the MopR-circuit from Acinetobacter sp. DF4 [64]. 
Modifying the sensor domain of DmpR by random mutations resulted in strains with an increased 
sensitivity to phenols and a broader range of detection [65].  
Leedjarv et al. reconstructed an MBS based on the DmpR system (P. fluorescens OS8 
[pDNdmpRlux]) and determined the bioavailable fractions of phenols in dump leachates and 
contaminated groundwater samples [66]. Since phenols are sufficiently water soluble, the MBS was 
calibrated in the classical ‘equilibrium’ mode (Fig. 3). The MBS-assay detected phenols in almost all 
samples, but the bioavailable fractions varied enormously, ranging from 0 to almost 100% of the total 
chemically-determined phenol amount in the sample. This demonstrated the great importance of taking 
compound bioavailability in samples into consideration for risk and bioremediation assesments. 
Sandhu and colleagues addressed the question of phenol bioavailability in the air nearby plant-leaves. 
Airborne phenol was detected using an MBS-assay directly on the plant leaves with P. fluorescens 
strain A506, expressing GFP under control of a mutated DmpR [65,67]. Their results showed that the 
sensors-reporter cells were able to detect phenol on plant leaves exposed to phenols in the vapour 
phase. Interestingly, the phenol concentration reported by the cells was more than tenfold higher than 
the chemically-determined phenol concentration in the air, which the authors interpreted as an 
accumulation of phenol on leaves.  
Jaspers et al. developed an MBS-assay for the detection of 2-hydroxybiphenyl, a disinfectant and 
fungicide, based on the HbpR transcription activator of Pseudomonas azelaica [68]. Classical 
incubation assays in aqueous solution resulted in method detection limits of 0.5 µM, but this could be 
lowered some twentyfold by using a hypersensitive mutant of HbpR [69]. A hybrid assay was then 
developed which would detect bio-accumulation of 2-hydroxybiphenyl via crab urine, and this showed 
that the crabs concentrated 2-hydroxybiphenyl up to 100-fold after being exposed in contaminated 
seawater for one week (Lewis et al, unpublished). 
Using a bacterium degrading 2,4-D and producing luciferase under control of the regulatory protein 
TfdR and PDII promoter from Cupriviadus necator JMP134 [61], Toba and Hay developed a solid-
phase MBS-assay for the detection of 2,4-D in soil [70]. In this assay the sensor-reporter cells were 
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spotted onto filter discs that were brought in direct contact for ≈ 60 min with the contaminated soil 
sample, after which the cells were retrieved and luciferase expression was analysed. Under appropriate 
moisture conditions, the MBS-assay detected 2,4-D at amounts between 1 and 50 mg/kg soil. Because 
these MBS cells degrade 2,4-D it would be conceivable to replace the luciferase reporter for GFP, 
expose for longer times and obtain a 2,4-D bioaccessibility assay – similar as outlined above for 
phenanthrene [55].  
MBS assays for polychlorinated biphenyls (PCBs) and oils 
It is particularly challenging to obtain MBSs for PCBs, since no bacterial systems are known that 
can sense PCBs and trigger gene expression. PCBs are ubiquitous in the environment at low 
concentrations, are toxic and poorly degraded. PCBs have been shown to cause a large variety of 
health effects, which is more severe for the higher chlorinated congeners [71]. Because of the lack of 
appropriate sensory proteins in bacteria, most developments have relied on using co-induction 
involving further uncharacterized activator proteins. For example, a PCB-degrading Ralstonia 
eutropha served as a host strain for the construction of a MBS (R. eutropha ENV307 [pUTK60]). The 
strain expresses bacterial luciferase from the PbphA1 promoter under control of an unidentified 
regulatory protein [72]. Although it is not clear whether this sensor-reporter bacterium directly senses 
chlorinated biphenyls or one of their metabolites, the MBS-assay enabled detection of biphenyl, 
monochlorinated biphenyls and Aroclor 1242 (a PCB mixture) in aqueous solution down to 1 mg/L. 
More recently, biosensor-reporter strains were used for PCB detection via its metabolites 3-
chlorobenzoate [73] or chloromuconic acids [74]. Furthermore, the aforementioned HbpR system in E. 
coli was used in an assay to detect hydroxylated PCBs in aqueous solution and in human serum, with 
the idea of detecting metabolites in animals and human exposed to PCBs [75]. Interestingly, some 
hydroxylated PCBs were detectable at concentrations as low as 10 nM and serum as assay medium 
was found to result in higher reporter output in the assay [75]. Finally, most recently we ourselves 
showed that mutants of the HbpR regulatory protein can be obtained which enable direct detection of 
2-chlorobiphenyl and triclosan [69]. None of those MBS-assays so far really addressed the issue of 
PCB bioavailablity or bioaccessibility, except indirectly the one using human serum [75]. 
Another compound class for which bioavailability and bioaccessibility are important issues, are 
alkanes. Alkanes are common constiuents of crude oil, natural gas and oil products, but come in a large 
variety of different chain lengths, branchings or cyclic forms (e.g., cyclohexane). Their environmental 
fate strongly depends on the number of carbon atoms, their solubility in water being inversely 
proportional to this number [35]. Although their acute and chronic toxicity are not extremely high, 
they form good indicators for oil pollution in the environment. Very few bacterial biosensor-reporter 
cells were constructed for alkane detection. The first described strain produced bacterial luciferase 
under control of the AlkS regulatory protein and PalkB promoter from Pseudomonas oleovorans [76]. 
Assays with the AlkS-MBS efficiently detected linear alkanes with chain lengths from C6 to C10 at 
nominal concentrations as low as 10 nM [76, 77]. Poor reporter signals were obtained with linear 
alkanes with longer chain lengths, with branched alkanes or cycloalkanes [76]. Because short-chain 
alkanes are very volatile, gas-phase based MBS-assays can be used like described for naphthalene 
detection. Consequently, decreasing the volume of gas phase in the assay helps to lower the apparent 
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method detection limit with sensor-reporter cells in aqueous suspension [77]. An example of the 
functioning and calibration of this MBS is presented in Box 1. The detection of long-chain alkanes by 
MBS has proven to be very difficult, probably because of extremely low aqueous solubility (≈10 nM 
[78]), and thus very low bioavailability fraction. As a proof of principle, however, we previously 
studied the octane mass-transfer from a point source through the aqueous phase by using an E. coli 
strain with octane-inducible GFP formation [77]. This strain could not degrade but only detect octane 
and, therefore, could not form a sink driving further diffusion from the source. Octane diffusion 
gradients could be detected over a length of 2.5 cm in as short as 30 minutes [77]. 
Conclusions 
We illustrated here that microbial sensors, and in particular bacterial sensors, can easily be designed 
for a wide variety of purposes. For the sake of shortness, we have omitted any further examples of 
MBS for heavy metals or toxicity, which have been recently reviewed elsewhere [4,14]. Leaning on 
the tools of genetic engineering, today’s huge genomic resources and the natural diversity within the 
microbial world, there is little limitation to our imagination for designing MBSs. In addition, we have 
shown that a plethora of assay forms can be easily conceived. Cultivation of bacterial cells – the heart 
of the MBS-assay - is easy, and production costs are very low. Method detection limits of MBS-
assays, as we have demonstrated, are often in the nanomolar range, thereby competing effectively with 
existing chemical analytics. Despite these aspects, MBS-assays are still rarely applied outside research 
laboratories [79]. Convincing data have been produced which demonstrate field robustness, good 
measurement precision and accuracy of MBS-assays in comparison to chemical analytics, as in the 
case of arsenic in groundwater [80] or rice [81]. It is high time that regulatory authorities accept MBS 
as realistic alternative for a variety of analytical procedures, which would certainly help their 
implementation. In addition, MBS could offer excellent possibilities for assaying the complex nature 
of bioavailable and bioaccessible fractions in thousands of cases of severe and toxic pollution, which 
currently cannot be easily addressed. We are confident that MBS sensing-reporting technology will 
contribute to fill this gap in the near future. 
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